Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rhythm Pharmaceuticals (RYTM) Current Assets (2016 - 2025)

Historic Current Assets for Rhythm Pharmaceuticals (RYTM) over the last 10 years, with Q3 2025 value amounting to $494.8 million.

  • Rhythm Pharmaceuticals' Current Assets rose 4538.42% to $494.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $494.8 million, marking a year-over-year increase of 4538.42%. This contributed to the annual value of $374.2 million for FY2024, which is 2138.79% up from last year.
  • According to the latest figures from Q3 2025, Rhythm Pharmaceuticals' Current Assets is $494.8 million, which was up 4538.42% from $360.7 million recorded in Q2 2025.
  • In the past 5 years, Rhythm Pharmaceuticals' Current Assets ranged from a high of $494.8 million in Q3 2025 and a low of $235.8 million during Q1 2024
  • Over the past 5 years, Rhythm Pharmaceuticals' median Current Assets value was $340.3 million (recorded in 2024), while the average stood at $338.2 million.
  • Per our database at Business Quant, Rhythm Pharmaceuticals' Current Assets soared by 5989.21% in 2021 and then crashed by 3850.33% in 2022.
  • Over the past 5 years, Rhythm Pharmaceuticals' Current Assets (Quarter) stood at $308.4 million in 2021, then increased by 14.87% to $354.2 million in 2022, then dropped by 12.98% to $308.3 million in 2023, then rose by 21.39% to $374.2 million in 2024, then soared by 32.23% to $494.8 million in 2025.
  • Its Current Assets stands at $494.8 million for Q3 2025, versus $360.7 million for Q2 2025 and $369.3 million for Q1 2025.